Skip to content

LAVA Therapeutics NV Sustainability Reports

LAVA Therapeutics N.V. is a clinical-stage biopharmaceutical company that develops bispecific gamma-delta T-cell engagers to treat cancer.

Sector: Manufacturing

Country: Netherlands

Exchange: Nasdaq

FIGI: BBG00L04L554

1 reports from 2021 to 2021